sb 220025 has been researched along with Adjuvant Arthritis in 1 studies
SB 220025: inhibits p38 mitogen-activated protein kinase; structure in first source
SB220025 : Am member of the class of imidazoles carrying piperidin-4-yl, 4-fluophenyl and 2-aminopyrimidin-4-yl substituents at posiitons 1, 4 and 5 respectively.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Graneto, MJ | 1 |
Kurumbail, RG | 1 |
Vazquez, ML | 1 |
Shieh, HS | 1 |
Pawlitz, JL | 1 |
Williams, JM | 1 |
Stallings, WC | 1 |
Geng, L | 1 |
Naraian, AS | 1 |
Koszyk, FJ | 1 |
Stealey, MA | 1 |
Xu, XD | 1 |
Weier, RM | 1 |
Hanson, GJ | 1 |
Mourey, RJ | 1 |
Compton, RP | 1 |
Mnich, SJ | 1 |
Anderson, GD | 1 |
Monahan, JB | 1 |
Devraj, R | 1 |
1 other study available for sb 220025 and Adjuvant Arthritis
Article | Year |
---|---|
Synthesis, crystal structure, and activity of pyrazole-based inhibitors of p38 kinase.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Collagen; Crystallography, X-Ray; Male; Mice | 2007 |